Jinyao Pharmaceutical (600488.SH) subsidiary obtains drug registration certificate for bupivacaine hydrochloride injection.

Zhito Finance APP News: Jinyao Pharmaceutical (600488.SH) announced that recently, its subsidiary Hubei Jinyao Pharmaceutical Co., Ltd. received the Drug Registration Certificate for Bupivacaine Hydrochloride Injection approved and issued by the National Medical Products Administration. Bupivacaine Hydrochloride Injection is used for local infiltration anesthesia, peripheral nerve block, and intraspinal block.